Non-Alcoholic Fatty Liver Disease (NAFLD) is one of the most common chronic causes of liver disease in the U.S. It’s estimated that about 25% of adults in the U.S. have NAFLD, and many don’t even know it. 

Non-alcoholic steatohepatitis (NASH) is the more severe form of NAFLD. NASH is liver inflammation and damage caused by a buildup of fat in the liver. Inflammation and liver cell damage can cause fibrosis, or scarring, of the liver. Because of the damage, the liver doesn’t work as well as it should.

If you have been told you have fatty liver or have risk factors such as obesity, diabetes, or high cholesterol and know that you need to seek help for your condition, our program could be the answer you’ve been looking for. And if you have not been tested, we can help with that as well.

Treating liver disease can be expensive, and that can be overwhelming. Summit Clinical Research’s “Fight Fatty Liver” campaign offers you a fighting chance to get professional, free treatment when you join our clinical trial. We offer free screening, a state-of-the-art program, and your patient navigator to help you win your fight with liver disease.